National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials (PDQ®)
Patient VersionHealth Professional Version
Last Modified: 7/30/2007     First Published: 8/1/1998  
Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Colorectal Cancer Drugs Require Careful Patient Selection

Cetuximab for Advanced Lung Cancer

Past Highlights
BreastCancerTrials.org
Phase III Randomized Study of Conventional Versus Laparoscopic-Assisted Surgery for Colorectal Cancer

Alternate Title
Basic Trial Information
Objectives
Entry Criteria
Expected Enrollment
Outline
Published Results
Trial Contact Information
Registry Information

Alternate Title

Conventional Surgery Compared With Laparoscopic-Assisted Surgery in Treating Patients With Colorectal Cancer

Basic Trial Information

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Closed


18 and over


Other


MRC-CLASICC
NYCTRU-CLASICC, EU-98014, ISRCTN74883561, NCT00003354

Objectives

  1. Determine whether longitudinal and circumferential resection margins and lymphatic clearances obtained during laparoscopic surgery are different from those obtained with conventional open surgery in patients with colorectal cancer.
  2. Compare the patterns of loco-regional or distant metastatic spread after these two surgical methods in these patients.
  3. Compare the morbidity and mortality rates in these patients after these two surgical methods, particularly in terms of the technical or thromboembolic complications that may develop as a consequence of prolonged pneumoperitoneum.
  4. Compare the disease-free or overall survival of these patients after these two operative procedures.
  5. Determine, in those patients in whom laparoscopic surgery fails, which investigatory modalities are appropriate for providing pre-operative indications that a patient is an inappropriate candidate for laparoscopic dissection.
  6. Compare the differences in quality of life between the two operative procedures, particularly in patients with advanced disease.

Entry Criteria

Disease Characteristics:

  • Histologically confirmed colorectal cancer


  • Must be suitable for elective surgical resection by right hemicolectomy, left hemicolectomy, sigmoid colectomy, anterior resection or abdomino-perineal resection


  • No adenocarcinoma of the transverse colon


  • No synchronous multiple adenocarcinomas


Prior/Concurrent Therapy:

Biologic therapy:

  • Not specified

Chemotherapy:

  • Not specified
  • Adjuvant chemotherapy allowed

Endocrine therapy:

  • Not specified

Radiotherapy:

  • Preoperative radiotherapy must be administered before randomization into this trial
  • Adjuvant radiotherapy allowed

Surgery:

  • See Disease Characteristics

Patient Characteristics:

Age:

  • 18 and over

Performance status:

  • Not specified

Life expectancy:

  • Not specified

Hematopoietic:

  • Not specified

Hepatic:

  • Not specified

Renal:

  • Not specified

Pulmonary:

  • No contraindication to pneumoperitoneum such as severe cardio-respiratory disease

Other:

  • No acute intestinal obstruction
  • No prior malignancy within the past 5 years, except basal cell carcinoma, carcinoma in situ of the cervix, or prostate cancer
  • Not pregnant
  • No gastrointestinal disease that requires surgical intervention, e.g., Crohn's disease, chronic ulcerative disease, familial polyposis

Expected Enrollment

1200

Approximately 1,200 patients will be accrued for this study within 5 years.

Outline

This is a randomized, multicenter study.

Patients undergo laparoscopic surgery or conventional open surgery.

Patients are followed at 1 and 3 months following surgery, then every 3 months for the first year, every 4 months for the second year, and then every 6 months thereafter.

Published Results

Guillou PJ, Quirke P, Thorpe H, et al.: Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 365 (9472): 1718-26, 2005 May 14-20.[PUBMED Abstract]

Jayne DG, Brown JM, Thorpe H, et al.: Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg 92 (9): 1124-32, 2005.[PUBMED Abstract]

Jayne DG, Guillou PJ, Thorpe H, et al.: Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 25 (21): 3061-8, 2007.[PUBMED Abstract]

Trial Contact Information

Trial Lead Organizations

Medical Research Council Clinical Trials Unit

P.J. Guillou, MD, Protocol chair
Ph: 44-113-206-6400

Registry Information
Official Title Conventional Versus Laparoscopic-Assisted Surgery in Colorectal Cancer
Trial Start Date 1996-07-01
Registered in ClinicalTrials.gov NCT00003354
Date Submitted to PDQ 1998-05-29
Information Last Verified 2001-01-08

Note: The purpose of most clinical trials listed in this database is to test new cancer treatments, or new methods of diagnosing, screening, or preventing cancer. Because all potentially harmful side effects are not known before a trial is conducted, dose and schedule modifications may be required for participants if they develop side effects from the treatment or test. The therapy or test described in this clinical trial is intended for use by clinical oncologists in carefully structured settings, and may not prove to be more effective than standard treatment. A responsible investigator associated with this clinical trial should be consulted before using this protocol.


Back to TopBack to Top

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov